NorthRock Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Sell |
2,166
-44
| -2% | -$5.57K | 0.01% | 558 |
|
|
2025
Q1 | $283K | Buy |
2,210
+33
| +2% | +$4.22K | 0.01% | 478 |
|
|
2024
Q4 | $288K | Sell |
2,177
-119
| -5% | -$15.7K | 0.01% | 478 |
|
|
2024
Q3 | $334K | Hold |
2,296
| – | – | 0.01% | 458 |
|
|
2024
Q2 | $315K | Sell |
2,296
-50
| -2% | -$6.86K | 0.01% | 454 |
|
|
2024
Q1 | $322K | Sell |
2,346
-201
| -8% | -$27.6K | 0.01% | 460 |
|
|
2023
Q4 | $346K | Buy |
+2,547
| New | +$346K | 0.01% | 421 |
|
|
2022
Q2 | – | Sell |
-3,555
| Closed | -$463K | – | 328 |
|
|
2022
Q1 | $463K | Sell |
3,555
-443
| -11% | -$57.7K | 0.04% | 180 |
|
|
2021
Q4 | $610K | Buy |
3,998
+681
| +21% | +$104K | 0.05% | 150 |
|
|
2021
Q3 | $552K | Sell |
3,317
-130
| -4% | -$21.6K | 0.05% | 150 |
|
|
2021
Q2 | $564K | Buy |
3,447
+90
| +3% | +$14.7K | 0.05% | 128 |
|
|
2021
Q1 | $505K | Buy |
3,357
+157
| +5% | +$23.6K | 0.05% | 119 |
|
|
2020
Q4 | $485K | Buy |
+3,200
| New | +$485K | 0.05% | 130 |
|